KUALA LUMPUR: Malaysia has been facing continuous pressure from pharmaceutical companies and their political allies ever since it used compulsory licensing (CL) to gain access to generic versions of a Hepatitis C drug in 2017.
But an international organisation Médecins Sans Frontières (MSF), or known as Doctors Without Borders, has stepped in to support Malaysia's position.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
